title: Expression of the multidrug resistance-associated protein (MRP) gene in urothelial carcinomas.
abstract: The intrinsic or acquired resistance of urothelial cancer to chemotherapy is one major obstacle to successful treatment. Generally, the expression level of P-glycoprotein in urothelial cancer is low, so we accordingly investigated the expression of multidrug resistance-associated protein (MRP). We examined the expression of MRP mRNA by means of slot-blotting samples of 11 renal pelvic and/or ureteral tumors, 33 bladder tumors, one lung metastasis from a ureter tumor, 7 non-cancerous urothelia from patients with transitional-cell carcinoma (TCC) and one urothelium from a patient with renal-cell carcinoma (RCC). We also estimated, by Southern blotting, whether or not the MRP gene was amplified in clinical specimens that overexpressed MRP mRNA. MRP was detected immunohistochemically using a polyclonal antibody against MRP. In all, 5 of 11 renal pelvic and/or ureter tumors (45.5%), 17 of 33 bladder tumors (51.5%) and 4 of 7 non-cancerous urothelia of TCC patients (57.1%) expressed more than 2-fold the MRP mRNA levels of drug-sensitive human KB cells. There was no significant difference in the MRP mRNA level between primary and recurrent tumors. Low-grade urothelial carcinomas (G1 and G2 TCCs) expressed significantly higher levels of MRP mRNA than the high-grade G3 TCC. The MRP gene was not amplified in urothelial carcinomas, irrespective of their expression levels of MRP mRNA. Immunohistochemically, MRP was located mainly on the plasma membrane, but also detected on the cytoplasm of cancer cells. MRP may be one mechanism responsible for intrinsic drug resistance in low-grade urothelial cancer.
authors.affiliation: Institute for Cancer Research, Faculty of Medicine, Kagoshima University, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Kubo
authors.forename: T
authors.initials: T
authors.lastname: Sumizawa
authors.forename: K
authors.initials: K
authors.lastname: Koga
authors.forename: K
authors.initials: K
authors.lastname: Nishiyama
authors.forename: Y
authors.initials: Y
authors.lastname: Takebayashi
authors.forename: Y
authors.initials: Y
authors.lastname: Chuman
authors.forename: T
authors.initials: T
authors.lastname: Furukawa
authors.forename: S
authors.initials: S
authors.lastname: Akiyama
authors.forename: Y
authors.initials: Y
authors.lastname: Ohi
mesh_terms: D018528:ATP-Binding Cassette Transporters / Q000032:analysis / Q000096:biosynthesis* / Q000235:genetics; D015152:Blotting, Northern / Q000379:methods; D015139:Blotting, Southern / Q000379:methods; D002295:Carcinoma, Transitional Cell / Q000235:genetics* / Q000473:pathology; D018432:Drug Resistance, Multiple / Q000235:genetics*; D015870:Gene Expression; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods; D008175:Lung Neoplasms / Q000737:chemistry / Q000556:secondary; D027425:ATP-Binding Cassette, Sub-Family C Proteins; D009693:Nucleic Acid Hybridization / Q000379:methods; D012333:RNA, Messenger / Q000032:analysis; D012334:RNA, Neoplasm / Q000737:chemistry; D014571:Urologic Neoplasms / Q000737:chemistry / Q000235:genetics* / Q000473:pathology; D019459:Urothelium / Q000737:chemistry / Q000473:pathology*
chemical_list: D018528:ATP-Binding Cassette Transporters; D027425:ATP-Binding Cassette, Sub-Family C Proteins; D012333:RNA, Messenger; D012334:RNA, Neoplasm